Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 | Q13639 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.51 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29397805 | 1.00 | HTR4 (1.00) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| Maleic Acid SCHEMBL2942174 | 0.95 | HTR4 (0.90) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| SCHEMBL29626583 | 0.94 | HTR4 (1.00) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| SCHEMBL7293994 | 0.94 | HTR4 (0.89) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| SCHEMBL7300971 | 0.90 | HTR4 (0.81) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| Maleic Acid SCHEMBL7295111 | 0.90 | HTR4 (0.81) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| Fumaric Acid SCHEMBL7295114 | 0.90 | HTR4 (0.81) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| SCHEMBL7300888 | 0.87 | HTR4 (0.77) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| Hydrochloric Acid SCHEMBL7291228 | 0.86 | HTR4 (0.76) | HTR4CYP2C9PMP22NPSR1CYP1A2 | |
| SCHEMBL7294699 | 0.86 | HTR4 (0.76) | HTR4CYP2C9PMP22NPSR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1503764-B1 | 5-HT4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEART FAILURE | SERODUS AS (NO) | 2010-01-06 | — | — | EP | claimed |
| EP-0501322-B1 | 3-Piperidinylmethylcarboxylate substituted indoles | GLAXO GROUP LTD (GB) | 1996-09-04 | — | — | EP | claimed |
| EP-0501322-A1 | 3-Piperidinylmethylcarboxylate substituted indoles | GLAXO GROUP LIMITED (GB) | 1992-09-02 | — | — | EP | claimed |
| US-20220323456-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2022-10-13 | — | — | US | disclosed |
| US-11337984-B2 | Methods for treating, diagnosing and prognosing a haematological malignancy | INSTITUT DE RECERCA CONTRA LA LEUCÉMIA JOSEP CARRERAS (ES) | 2022-05-24 | — | — | US | disclosed |
| US-20210228593-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2021-07-29 | — | — | US | disclosed |
| EP-3160472-B1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INST DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (ES) | 2020-03-11 | — | — | EP | disclosed |
| US-20190343843-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2019-11-14 | — | — | US | disclosed |
| CN-106471373-B | For treating, diagnosing and the method for prognosis Malignancy | 约瑟卡雷拉斯白血球过多症研究所 | 2019-08-23 | — | — | CN | disclosed |
| US-10195207-B2 | Methods for treating, diagnosing and prognosing a haematological malignancy | INSTITUT DE RECERCA CONTRA LA LEUCÈMIA JOSEP CARRERAS (ES) | 2019-02-05 | — | — | US | disclosed |
| US-20170143735-A1 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS (ES) | 2017-05-25 | — | — | US | disclosed |
| US-6294555-B1 | SEROTONIN HT3 RECEPTOR ANTAGONIST FOR GASTROINTESTINAL DISORDERS | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 2001-09-25 | — | — | US | disclosed |
| EP-1076055-A1 | 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS | Dainippon Pharmaceutical Co., Ltd. (JP) | 2001-02-14 | — | — | EP | disclosed |
| EP-0979818-A1 | BENZOIC ACID COMPOUNDS AND MEDICINAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2000-02-16 | — | — | EP | disclosed |
| EP-0873990-A1 | BENZOIC ACID COMPOUNDS AND MEDICINAL USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-10-28 | — | — | EP | disclosed |
| US-5763459-A | Medicaments for the treatment of anxiety | SMITHKLINE BEECHAM P.L.C. (GB) | 1998-06-09 | — | — | US | disclosed |
| EP-0774460-A1 | BENZOIC ACID COMPOUND AND USE THEREOF AS MEDICINE | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |
| EP-0501322-B1 | 3-Piperidinylmethylcarboxylate substituted indoles | GLAXO GROUP LTD (GB) | 1996-09-04 | — | — | EP | disclosed |
| WO-1992014727-A1 | 3-PIPERIDINYLMETHYLCARBOXYLATE SUBSTITUTED INDOLES | GLAXO GROUP LIMITED (GB) | 1992-09-03 | — | — | WO | disclosed |
| EP-0501322-A1 | 3-Piperidinylmethylcarboxylate substituted indoles | GLAXO GROUP LIMITED (GB) | 1992-09-02 | — | — | EP | disclosed |